OPEN END TURBO OPTIONSSCHEIN - BOSTON SCIENTIFIC | Real-time Bid/Ask 09:44:41 2024-05-30 am EDT | ||
| 2.86 EUR / 2.87 EUR | -0.87% |
|
| Current month | -9.97% | ||
| 1 month | -8.25% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BOSTON SCIENTIFIC CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-05-30 | 2.84 | -1.73% |
| 24-05-29 | 2.89 | +0.70% |
| 24-05-28 | 2.87 | +5.13% |
| 24-05-27 | 2.73 | -3.19% |
| 24-05-24 | 2.82 | -4.08% |
Delayed Quote Börse Stuttgart
Last update May 30, 2024 at 06:59 am EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BOSTON SCIENTIFIC CORPORATION |
| Issuer | J.P. Morgan |
| WKN | JK8GKL |
| ISIN | DE000JK8GKL2 |
| Date issued | 2024-04-26 |
| Strike | 106 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 3.1 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.25 € |
|---|---|
| Lowest since issue | 2.73 € |
| Spread | 0.01 € |
| Spread % | 0.35% |
Company Profile
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Sector
-
Ratings for Boston Scientific Corporation
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Boston Scientific Corporation
Sell
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
74.98
USD
Average target price
81.8
USD
Spread / Average Target
+9.10%
- Stock Market
- Certificates
- Certificat
